A Missouri judge slashed a $1.56 billion verdict against Bayer (OTC:BAYRY) to $611 million for three people who claimed its Roundup weed killer caused their cancer, by reducing punitive damages.
Bayer said on Friday it is appealing.

Roundup is among the most widely used weedkillers in the United States, though Bayer phased out sales for home use last year.
Though Bayer has won the majority of its more recent Roundup trials, plaintiffs have won more than $4 billion of verdicts, including $2.25 billion in a single case in January. Bayer is appealing those verdicts.